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ABSTRACT 
Objective: The present study aims to standardize four marketed brands of Balarishta, an Ayurvedic formulation viz. Baidyanath-Balarishta (BB), 
Dabur-Balarishta (DB), Zandu-Balarishta (ZB) and Nagarjuna-Balarishta (NB) with respect to their physicochemical (organoleptic properties, pH, 
specific gravity, total solid content, ethanol content, reducing and non-reducing sugar content), phytochemical and microbial parameters (total 
bacterial count, total fungal count and test for specific pathogens viz. P. aeruginosa, E. coli and S. aureus). It also aims to develop and validate a new 
highperformance thin layer chromatography (HPTLC) method for simultaneous determination of three major phytoconstituents present in 
Balarishta viz. withaferin A, gallic acid and ephedrine.  
Methods: ‘Protocol for testing Ayurveda, Siddha and Unani medicines’ was used as a reference for conducting standardization experiments. HPTLC 
method was developed on Camag Linomat-5 using silica gel 60 GF254 
Results: The results of standardisation tests obtained were compared with specifications mentioned in ‘Ayurvedic Pharmacopoeia of India 2008 
Volume 2, Part 2’ and a comparative data of each Balarishta formulation was generated for all the quality control parameters performed. A new, 
accurate, precise and robust HPTLC method was successfully developed with Retardation factor (Rf) of 0.17±0.02, 0.35±0.01 and 0.54±0.02 for 
ephedrine, gallic acid and withaferin A respectively. 
as the stationary phase and Toluene: Chloroform: n-propanol: Ethanol: Formic 
acid (6: 3: 1: 2: 1, v/v/v/v/v) as the mobile phase. The analytical method validation studies were performed as per International Conference on 
Harmonization-Quality (ICH-Q2 (R1)) guidelines.  
Conclusion: The results of this research work will serve as a valuable quality tool for routine quality control analysis of Balarishta formulations. 
Keywords: Balarishta, Standardisation, Withaferin A, Gallic acid, Ephedrine and HPTLC. 
© 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 
 
INTRODUCTION 
Ayurvedic knowledge originated in India more than 5,000 y ago and 
is often called the “Mother of All Healing” [1]. This ancient system of 
herbal medicines is being utilised by Indians and has also gained 
attention worldwide due to its long-term benefits in terms of overall 
wellness with no side effects. According to World Health 
Organization (WHO) estimates, the present demand for medicinal 
plants is about US $14 billion a year. About 88 % of the world’s 
inhabitants rely mainly on traditional medicine for their primary 
healthcare [2-5]. In spite of the long history of traditional use of 
herbal medicines, the number of reports of people experiencing 
negative effects, caused by the use of herbal drugs, has also been 
increasing. Poor quality of herbal medicines due to insufficient 
attention being paid to the quality assurance and control of these 
products is one of the major underlying reasons. Moreover, the 
practice of knowingly or unknowingly mixing adulterants in herbal 
formulations is rampant [6]. Due to the complex nature and inherent 
variability of the constituents of plant-based drugs, it is difficult to 
establish quality control parameters. The development of authentic 
methods which can reliably determine the quality of formulation as 
a whole and also of main phytoconstituents responsible for the 
activity is need of the hour. Asava-arishta is considered one of the 
most valuable therapeutics in Ayurvedic system of herbal medicines. 
A unique characteristic of these formulations is that they are 
prepared by fermentation of herbal decoction (in the case of arishta) 
and herbal infusion (in the case of asava) [7]. The fermentation 
process carried out by tannin-rich spores of Woodfordia fructicosa or 
Madhuka indica flowers and starch (in the form of jaggery, honey or 
sugar) results in the generation of alcohol in the product that acts as 
a preservative and also helps in the extraction of active principles. 
Thus, these formulations are known to possess enhanced 
therapeutic activity than the herbs alone and these are readily 
acceptable because of their sweet taste.  
  
Table 1: Composition of Balarishta formulation [9] 
S. No. Herbal composition Common name Plant part Quantity(kg) 
1. Sida cordifolia Bala Root 4.8 
2. Withania somnifera Ashwagandha Root 4.8 
3. Water Jala for decoction  49.15 
 reduced to  12.28 
4. Jaggery Guda  14.4 
5. Woodfordia fructicosa Dhataki Flower 0.768 
6. Ipomea digitata Payasya Sub. Root 0.096 
7. Ricinus communis Eranda Root 0.096 
8. Pluchea lanceolata Rasna Leaf 0.048 
9. Elettaria cardamomum Elaichi Seed 0.048 
10. Paederia foetida Prasarini Whole plant 0.048 
11. Syzgyium aromaticum Lavanga Flower  0.048 
12. Vetiveria zizanioides Usira Root 0.048 
13. Tribulus terrestris Goksura Fruit 0.048 
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Balarishta, belonging to the category of asava-arishta, is used as a 
medicament to improve immunity and to treat diseases like 
arthritis, neuralgia, hemiplegia and spondolysis [8]. The 
therapeutic effect of this formulation comes from the major herbs 
present viz. Withania somnifera (Ashwagandha) and Sida cordifolia 
(Bala). The formulation composition of Balarishta as given in 
Ayurvedic Pharmacopoeia of India is given in table 1 [9]. The 
quantity of each ingredient in all four marketed preparation is 
variable and is given in table 2 as per the composition mentioned 
in their labels. 
 
Table 2: Composition of marketed Balarishta formulation 
S. No. Herbal composition Common name Quantity (g/10 ml) 
BB DB ZB NB 
1. Sida cordifolia Bala 1.366 2.3 3.846 1.953 
2. Withania somnifera Ashwagandha 1.366 2.3 3.846 1.953 
3. Jaggery Guda 4.1 6.9 - 5.859 
4. Sugar Sakara - - 11.538 - 
5. Woodfordia fructicosa Dhataki 0.218 0.368 0.576 0.312 
6. Ipomea digitata Payasya, Kshiravidhari 0.0273 0.046 0.0714 0.0392 
7. Ricinus communis Eranda 0.0273 0.046 0.0714 - 
8. Pluchea lanceolata Rasna 0.0136 0.0229 0.0354 0.0392 
9. Elettaria cardamomum Elaichi, Ela 0.0136 - - 0.0392 
10. Paederia foetida Prasarini 0.0136 0.0229 0.0354 0.0392 
11. Syzgyium aromaticum Lavanga 0.0136 0.0229 0.0354 - 
12. Vetiveria zizanioides Usira 0.0136 0.0229 0.0354 0.0196 
13. Tribulus terrestris Goksura 0.0136 0.0229 0.0354 0.0196 
14.  sukshmaila - 0.0229 0.0354 - 
15.  panchaangulam - - - 0.0392 
16.  devapushpam - - - 0.0196 
17. Water Jala qs qs Qs qs 
 
The present study aims to standardize four marketed Balarishta 
formulations viz. BB, DB, ZB and NB with respect to their 
physicochemical, photochemical and microbial parameters. It also aims 
to develop and validate HPTLC method for simultaneous identification 
and quantitative determination of three major phytoconstituents 
present in Balarishta viz. withaferin A, gallic acid and ephedrine.  
MATERIALS AND METHODS 
Materials 
The marketed Balarishta formulations were procured from local 
shops in the Mumbai market. Withaferin A was purchased from 
Natural Remedies Pvt. Ltd., Bangalore, while ephedrine and gallic 
acid were purchased from Total Herb Solution Pvt. Ltd., Mumbai. A 
gift sample of Withaferin A was provided by Dr. Lal Hingorani, 
Director, Pharmanza Herbal Pvt. Ltd., Anand, Gujarat. The solvents 
and chemicals used in this research project were of analytical grade. 
Camag Linomat-5 HPTLC application system and Camag HPTLC 
densitometer were used for analytical method development and 
validation studies.  
Physicochemical studies 
Organoleptic properties 
Balarishta formulations were evaluated for their organoleptic 
properties viz. odour, appearance and taste. 
pH 
The pH of each formulation was measured using a calibrated pH 
meter [10]. 
Specific gravity 
The specific gravity of each formulation was determined in triplicate 
using 10 ml specific gravity bottles and the following formula [10]- 
Specific gravity of liquid (formulation) = (weight of 10 ml of liquid 
÷10) ÷ (weight of 10 ml of water ÷10)  
Total solid content 
The total solid content of each formulation was determined by taking 
10 ml of the formulation in porcelain evaporating dish and heating it 
on an electric water bath at 60–70 ˚C followed by placing in an oven at 
105 ˚C until a constant weight of residue was obtained [10]. 
Ethanol content 
25 ml of each formulation was taken in a 500 ml round bottom flask, 
diluted with 150 ml of distilled water and was attached to 
distillation unit after adding few porcelain pieces. It was distilled 
and not less than 90 ml of distillate was collected in 100 ml 
volumetric flask and diluted to volume with distilled water. The 
relative density of this solution was determined and the alcohol 
content was reported by comparing its value with the table 
mentioned in Indian Pharmacopoeia 2014, volume 1 [11]. 
Reducing and non-reducing sugar content 
This was determined by Lane Eymon’s method of titrimetric analysis 
using Fehling’s solution [12]. 
(i) Determination of Fehling’s factor: 1 g of sucrose was hydrolyzed 
by adding 1 ml of concentrated Hydrochloric acid (HCl) and volume 
was made up to 100 ml with water. This was kept for 24 h, followed 
by titration against Fehling’s solution (5 ml of each Fehling A and 
Fehling B solution) using methylene blue as indicator. Fehling factor 
was determined using following formula- 
Fehling factor (for invert sugar) = (Titre × weight of sucrose (g)) ÷ 100  
(ii) Determination of reducing sugar content: 10 ml of formulation 
was taken in 100 ml volumetric flask and volume was made up with 
water. This solution was titrated against Fehling’s solution (5 ml of 
each Fehling A and Fehling B solution) using methylene blue as 
indicator in triplicate and the average tire value was used to 
calculate percent reducing sugar content using following formula- 
Percent reducing sugar (%w/v) = (Fehling factor × dilution factor × 
100) ÷ (Average titre value (ml))  
(iii) Determination of total sugar content: 10 ml of formulation was 
hydrolysed by adding 1 ml of concentrated HCl and volume was 
made up to 100 ml with water. This was kept for 24 h, followed by 
titration against Fehling’s solution (5 ml of each Fehling A and 
Fehling B solution) using methylene blue as indicator in triplicate 
and the average titre value was used to calculate percent total sugar 
content using following formula- 
Percent total sugar (%w/v) = (Fehling factor × dilution factor × 100) 
÷ (Average titre value (ml))  
(iv) Determination of non-reducing sugar content: The non-reducing 
sugar content value was determined using following formula- 
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Percent non-reducing sugar (%w/v) = (percent total sugar 
(%w/v))–(percent reducing sugar (%w/v)) 
Phytochemical evaluation 
Phytochemical evaluation for the presence of plant secondary 
metabolites like alkaloids, glycosides, flavonoids, steroids, tannins 
and phenolics, carbohydrates and proteins in the methanolic extract 
of formulation residue was conducted using qualitative tests as 
mentioned in the standard text [13]. 
Microbial examination 
This involved determination of total bacterial count, total fungal 
count and test for specific pathogens viz. P. aeruginosa, E. coli and S. 
aureus. Each of the microbial experiments was performed in a 
sterilized laminar air flow chamber. This experiment was performed 
in a sample taken from the newly opened bottle. The sample stock 
solution was prepared by taking 10 ml of formulation and making up 
the volume to 100 ml with Soyabean Casein Digest (SCD) broth. 1 ml 
of this stock solution was used as a test sample for all the microbial 
tests. Four control petri plates viz. medium control, diluent i.e. broth 
solution (negative) control, positive control (bacteria/fungus 
culture) and environment control were set for each experiment. For 
total bacterial count, the test and control samples were incubated in 
Soybean Casein Digest Agar (SCDA) medium at 35 ˚C for 2-3 d. For 
total fungal count, the test and control samples were incubated in 
Sabouraud Dextrose Agar (SDA) medium at 25 ˚C for 5-7 d. The test 
for the presence of specific pathogen viz. P. aeruginosa, E. coli and S. 
aureus were determined by its characteristic growth of green, pink 
and light yellow coloured colonies when incubated in characteristic 
Cetrimide agar, Mac Conkey agar and Vogel Johnson agar medium 
respectively at 35 ˚C for 2-3 d [10]. 
HPTLC method development 
Development and optimisation of mobile phase 
A series of mobile phase systems reported for individual 
determination of ephedrine, gallic acid and withaferin A were 
explored in order to achieve good resolution of the selected 
phytoconstituents. However, modification in mobile phase was 
required as none of these trials were successful in resolving all three 
of them. 
Preparation of sample 
Balarishta formulation was heated on an electric water bath at 60-70 
°C to evaporate the self-generated alcohol and obtain a residue. 10-
12 grams of this residue was dissolved in around 40 ml of water 
[Residue in water-(R+H2O)] and transferred in 250 ml separating 
funnel. This solution was extracted with ethyl acetate (50 ml × 3 
times) so as to extract withaferin A and gallic acid from the residue. 
For extraction of ephedrine, each formulation residue except for DB 
was made alkaline by adding around 40 ml of 0.1 N Sodium 
hydroxide (NaOH) [Residue in NaOH-(R+NaOH)], till the pH of 
sample reached 10-11 value. For DB, 40 ml of 1 N NaOH was 
required to make it alkaline (pH 10-11). The ethyl acetate fractions 
of each residue, both (R+H2
The filtrate was subjected to vacuum evaporation using Rotavap, to 
obtain the dried ethyl acetate fraction. This fraction was weighed and 
dissolved in ethyl acetate for further HPTLC analysis. This procedure 
was found to be the most suitable sample pre-treatment procedure for 
efficient extraction of the three markers. Fig. 1 gives a schematic 
representation of the optimised sample preparation procedure. 
O) and (R+NaOH) samples were 
collected separately and filtered through Whatmann filter paper.  
  
 
Fig. 1: Scheme for sample preparation of the Balarishta formulations 
 
Preparation of standard 
The stock solutions of each of the three reference standards were 
prepared in methanol. Accurately measured quantity of each 
reference standard was dissolved in methanol to get 200 ppm, 100 
ppm and 500 ppm stock solution of withaferin A, gallic acid and 
ephedrine respectively. 
HPTLC method validation studies 
The developed HPTLC method was validated as per ICH Q2 (R1) 
guidelines for the following parameters [14]. 
Linearity and range studies 
The linearity was evaluated in the concentration range of 4-28 
µg/band for ephedrine, 0.1-1 µg/band for gallic acid and 0.5-5 
µg/band for withaferin A. Peak area versus concentration was 
subjected to least square linear regression analysis and the slope, 
intercept and regression value for the calibration were determined. 
From the calibration plot, the concentration range which gave linear 
correlation between the peak area and the applied concentration 
was determined. 
Limit of detection (LOD) and limit of quantitation (LOQ) studies 
The LOD and LOQ for each marker were determined using the 
following expression- 
LOD = (3.3 × σ) ÷ S and LOQ = (10 × σ) ÷ S  
Where, σ is the standard deviation and S is the slope of the 
calibration curve. 
Accuracy studies 
Accuracy was evaluated through the percent recoveries of known 
amounts (80%, 100% and 120%) of each marker spiked on one sample 
solution. Percent recovery was calculated from the following equation- 
Percent Recovery = (Practical recovery ÷ Theoretical recovery) × 100. 
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Precision studies 
Ephedrine, gallic acid and withaferin A in the concentration of 20 
µg/band, 0.4 µg/band and 2 µg/band respectively were applied 
seven times on three different plates and percent coefficient of 
variation (% CV) between the peak area values were calculated after 
repeating the same experiment three times in a day (intraday 
precision) and on three different days (interday precision). 
Specificity studies 
The method was checked for the presence of any interference peaks 
from diluent and mobile phase. 
Robustness studies 
Robustness studies were carried out with an intentional variation in 
two chromatographic parameters viz. mobile phase composition and 
solvent front distance to determine its influence on the Rf value, 
peak area and peak shape of each standard. The mobile phase 
composition was altered by±0.5 ml of each solvent while the solvent 
front distance was altered by±10 mm from the optimized value. 
Quantitation of marker compounds 
Ephedrine, gallic acid and withaferin A were selected as marker 
compounds for the Balarishta formulation, and the developed 
analytical method was used for the quantitative estimation of the same 
in the four marketed Balarishta formulations viz. BB, DB, ZB and NB. 
RESULTS  
Physicochemical studies 
The results of all physicochemical tests are given in table 3. 
Organoleptic properties 
The Balarishta formulations were brown in colour, liquid with 
alcoholic odour and sweet taste. The ZB had very light brown muddy 
colour as compared to the other three brands. 
pH 
The pH of the four formulations was found to be within the 
specification range i.e. 3.4–4.6 given for Balarishta in Ayurvedic 
Pharmacopoeia of India [9].  
Specific gravity 
The specific gravity of the four formulations was found to be within 
the specification range i.e. 1.05–1.20 given for Balarishta in 
Ayurvedic Pharmacopoeia of India [9]. 
Total solid content 
Two out of the four formulations viz. DB and NB were found to 
comply with the specification limit of total solid content for 
Balarishta i.e. Not Less Than (NLT) 22 %w/v as mentioned in 
Ayurvedic Pharmacopoeia of India [9]. 
Ethanol content 
The four Balarishta formulations were observed to comply with the 
specification range of ethanol content for Balarishta i.e. 5-10 % as 
mentioned in Ayurvedic Pharmacopoeia of India [9]. 
Reducing and non-reducing sugar content 
The four brands of Balarishta except NB were found to comply with 
the specification limit for reducing sugar content i.e. NLT 14 %w/v. 
However, for non-reducing sugar content, only DB and NB were found 
to comply with the specification limit i.e. Not More Than (NMT) 1 
%w/v as mentioned in Ayurvedic Pharmacopoeia of India [9]. 
Phytochemical evaluation 
The methanolic extract of formulation-residue was found to contain 
alkaloids, steroids, tannins and phenolics, carbohydrates and 
proteins in all the four formulations. 
Microbial examination 
All the Balarishta formulations under study were found to comply 
with the specification limit for total bacterial count i.e. NMT 1× 
105Colony Forming Unit per ml (CFU/ml) and total fungal count i.e. 
NMT 1× 103CFU/ml as mentioned in the book ‘Protocol for testing 
Ayurveda, Siddha and Unani medicines’ [10]. P. aeruginosa and E. 
coli were absent in all four formulations. In the test for the presence 
of S. aureus, BB and NB showed the presence of characteristic light-
yellow coloured bacterial growth. However, the red colour of Vogel 
Johnson agar medium didn’t turn yellow as observed in positive 
control petri plate. On performing gram staining of the bacterial 
growth observed in both the samples, gram-positive rod-shaped 
bacteria were observed in BB sample Petri plate while gram positive 
cocci-shaped bacteria were observed in NB sample Petri plate. As S. 
aureus is gram positive cocci-shaped bacteria, NB might contain 
these bacteria. The Petri plates of the total bacterial count and the 
total fungal count is depicted in fig. 2 while the Petri plates of 
specific pathogen experiments are depicted in fig. 3. 
Optimised HPTLC method 
The optimised chromatographic conditions for HPTLC method 
development and validation and the chromatogram observed by this 
method are given in table 4 and fig. 4 respectively. 
HPTLC method validation studies 
The summary of all HPTLC validation parameters results is given in 
table 5. 
Linearity and range studies 
A linear correlation of the peak area and analyte concentration was 
observed at a concentration range of 8 to 28 µg/band (r2 =0.995), 
0.1 to 0.8 µg/band (r2 = 0.995) and 0.5 to 4 µg/band (r2
The developed method was accurate with average percent 
recoveries of 81.32%, 89.94% and 94.04% for ephedrine, gallic acid 
and withaferin A respectively. The results were calculated as shown 
in table 5. 
= 0.993) for 
ephedrine, gallic acid and withaferin A respectively. 
LOD and LOQ studies 
The calculated LOD and LOQ values were found to be 0.05 µg/band, 
0.003 µg/band, 0.01 µg/band and 0.16 µg/band, 0.009 µg/band, 0.038 
µg/band for ephedrine, gallic acid and withaferin A respectively. 
Accuracy studies 
 
Table 3: Physicochemical tests of Balarishta formulations 
S. No. Test Specification Balarishta formulations* 
BB DB ZB NB 
1 pH 3.4–4.6 3.82 (±0.00) 4.16 (±0.00) 3.97 (±0.00) 4.44 (±0.00) 
2 Specific gravity 1.05–1.20 1.1035 (±0.514) 1.0801 (±0.633) 1.0947 (±0.041) 1.0606 (±0.200) 
3 Total solid content NLT 22%w/v 23.95 (±0.945) 17.77 (±1.682) 29.67 (±0.611) 18.23 (±1.179) 
4 Ethanol content 5–10% v/v 9.53 (±0.605) 8.70 (±1.149) 9.20 (±1.086) 9.60 (±1.804) 
5 Reducing sugar content NLT 14%w/v 20.32 (±2.340) 15.82 (±1.823) 21.73 (±0.00) 13.51 (±0.00) 
6 
 
Non-reducing sugar content NMT 1%w/v 
 
1.41 (±0.00) 0.51 (±1.882) 4.58 (±0.00) 0.94 (±1.665) 
*mean (±Relative Standard Deviation), n = 3. 
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Control petri plates 
 




Control petri plates 
 
Fig. 2: Photo documentation of Petri plates of total bacterial count and total fungal count 
 
Test for P. aeruginosa using Cetrimide agar medium 
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Control petri plates 
 




Control petri plates 




Control petri plates 
Fig. 3: Photo documentation of petri plates of specific pathogens 
 
Table 4: Optimised HPTLC chromatographic conditions 
HPTLC instrument CAMAG Linomat 5 
Stationary phase Silica Gel 60 GF254 
Mobile phase Toluene: Chloroform: n-propanol: Ethanol: Formic acid (6: 3: 1: 2: 1, v/v/v/v/v) 
Observed Rf values Ephedrine: 0.17±0.02, Gallic acid: 0.35±0.01, Withaferin A: 0.54±0.02 
Bandwidth 8 mm 
Saturation time No saturation 
Solvent front distance 80 mm 
Detection lamp Deuterium 
Detection wavelength 254 nm 
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recovery Std. in 
sample 
(A) 




1 100 12.8 1160.25 2282.25 2785.1 3442.5 80.903% 81.32% 
2 100 16  1160.25 2738.5 3141.6 3898.75 80.57% 
3 100 19.2 1160.25 2873.2 3327.7 4033.45 82.50% 
Gallic acid 
1 10 0.32 3002.85 1883.55 4985.1 4886.4 102.01% 89.94% 
2 10 0.40 3002.85 2946.05 5159.6 5948.9 86.73% 
3 10 0.48 3002.85 3317.3 5124.05 6320.15 81.07% 
Withaferin A 
1 10 1.6 1271.05 2977.65 4044.1 4248.7 95.18% 94.04% 
2 10 2.0 1271.05 3644.55 4530.05 4915.6 92.15% 
3 10 2.4 1271.05 3956.55 4956.4 5227.6 94.81% 
 
 
Fig. 4: Chromatogram of ephedrine, gallic acid and withaferin A 
at optimized chromatographic conditions 
 
Precision studies 
The developed method was found to be precise. The results of 
interday and intraday precision studies of all three standards are 
given in table 6. 
Specificity studies 
The method was found to be specific for ephedrine, gallic acid and 
withaferin A with no interference peak of diluents and mobile phase 
at the Rf position of markers.  
 
Table 6: Summary of analytical method validation parameters 




Linearity (Regression value) 0.995 0.995 0.993 
Range (µg/band) 8-28 0.1-0.8 0.5-4 
LOD (µg/band) 0.05 0.003 0.01 
LOQ (µg/band) 0.16 0.009 0.038 
Accuracy (% recovery) 81.32% 89.94% 94.04% 
Precision-Intraday (%CV) 1.541% 1.069% 0.794% 
Precision–Interday (%CV) 1.482% 1.043% 0.825% 
Specificity for interference 
of diluent and mobile phase 
Specific Specific Specific 
Robustness for change in 
solvent front distance 
Robust Robust Robust 
 
Robustness studies 
There was no change in resolution, but the Rf values of all three 
markers were shifted down with decrease in mobile phase volume of 
each solvent by 0.5 ml. The resolution was distorted with an 
increase in Rf value when mobile phase volume of each solvent was 
increased by 0.5 ml. The method was found to be robust with both 
increase and decrease in solvent front distance by±10 mm. 
Quantitation of markers 
The ethyl acetate fraction of both (R+H2O) and (R+NaOH) samples 
of all four brands of Balarishta viz. BB, DB, ZB and NB were prepared 
and developed along with markers as shown in fig. 5 and fig. 6 and 
their respective peak chromatograms in fig. 7 and fig. 8. From the 
densitometric data of these samples, percent content of withaferin A, 
gallic acid and ephedrine in each of the formulation was calculated, 
and the percent content is mentioned in table 7. 
 
 
Fig. 5: HPTLC fingerprint of BB, DB samples and three marker 
standards at 254 nm 
 
 
Fig. 6: HPTLC fingerprint of ZB, NB samples and three marker 
standards at 254 nm 
 
DISCUSSION 
Arishta preparations undergo major changes in terms of their 
physicochemical, phytochemical, microbial and compositional 
parameters during the long fermentation process-major step in 
arishta formulation. Vinothkanna A et al. (2014) have observed and 
recorded periodic changes in organoleptic and biochemical 
parameters of Balarishta during fermentation process [15]. It is 
equally essential to evaluate quality parameters of finished products 
as that of evaluating raw materials. Preliminary phytochemicals 
screening and antioxidant activity evaluation on one of locally 
available Balarishta formulation was carried out by Rajalakshmy MR et 
al. (2011) and concluded to observe good antioxidant property [16]. 
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BB (R+H2 BB (R+NaOH) O) 
  
DB (R+H2 DB (R+NaOH) O) 
 
 
Fig. 7: Densitogram of BB, DB samples and three marker standards. 
 
ZB (R+H2 ZB (R+NaOH) O) 
  
NB (R+H2 NB (R+NaOH) O) 
  
Fig. 8: Densitogram of ZB, NB samples and three marker standards 
 
Table 7: Quantitation of markers in the marketed balarishta formulations 
S. No. Sample Percent content of (%w/v) 
Ephedrine Gallic acid Withaferin A 
1 BB 0.56200 0.00836 0.04004 
2 DB 0.01143 0.00056 0.00208 
3 ZB 0.00111 0.00009 0.00045 
4 NB 0.02535 0.00029 0.00074 
 
Spectroscopic method for standardization of Balarishta was 
performed by Vador N et al., (2012) which included determination of 
total phenolics, total flavonoids, total alkaloids and total saponins 
along with few physicochemical tests on one in-house preparation 
and two marketed formulations [17]. The result of this present study 
provides comparative quality assessment data of all four marketed 
Balarishta preparations with standards defined by Ayurvedic 
Pharmacopoeia of India. In order to corroborate the standardization, 
a novel HPTLC method was developed for simultaneous 
identification of three major phytoconstituents present in main 
herbs of Balarishta viz. ephedrine, withaferin A and gallic acid. 
CONCLUSION 
Standardisation of four different brands of an Ayurvedic 
formulation-Balarishta viz. BB, DB, ZB and NB was successfully 
carried out with respect to their physicochemical (organoleptic 
properties, pH, specific gravity, total solid content, total ethanol 
content, reducing and non-reducing sugar content), phytochemical 
and microbial parameters (total bacterial count, total fungal count 
and test for specific pathogens viz. P. aeruginosa, E. coli and S. 
aureus) and comparative data was generated. Also, a new, simple, 
accurate, precise and robust HPTLC method was successfully 
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developed for the simultaneous determination of ephedrine, gallic 
acid and withaferin A in all four Balarishta formulations. This 
method was validated as per the ICH Q2 (R1) guidelines. This 
method can be used for routine analysis and standardisation of 
Balarishta and other formulations containing these 
phytoconstituents, thereby increasing the scientific validity and 
quality of these herbal formulations. 
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